- Clinical Chemistry
Dr. Eric Kilpatrick is the Division Chief in Clinical Chemistry at Sidra Medicine. He is clinically responsible for delivering a quality Clinical Biochemistry service as well as Point of Care testing within the hospital and aims to establish the whole Pathology service as a hub for research, teaching and innovation.
As well as developing the clinical laboratory service at Sidra, Dr. Kilpatrick plans to continue his diabetes research in Qatar and has been jointly successful with Weill Cornell Medical College in receiving Qatar National Research Fund resource to further study the effects of varying glucose control on diabetes complications.
Dr. Kilpatrick is currently the honorary full Professor of Clinical Biochemistry at Hull York Medical School. He is also the former President of the UK’s main professional body in his specialty- the Association for Clinical Biochemistry and Laboratory Medicine – having just served as the youngest President in its 60 year history.
After graduating in medicine from the University of Glasgow in 1988, Dr. Kilpatric trained in Clinical Biochemistry in Glasgow and then Manchester before being appointed as the consultant Head of Department of Clinical Biochemistry at Hull Royal Infirmary in 1998. He subsequently led the 250 staff there from all laboratory disciplines as Clinical Director for Pathology.
Academically, he gained his higher MD degree from Glasgow in 1996, with his thesis combining his interest in the laboratory medicine and clinical diabetes. Since then, he has become an international authority on assessing glucose control in diabetes and has published ~150 articles peer-reviewed articles contributing, in 2006, to him becoming the first honorary full Professor from Hull at Hull York Medical School.
Dr Kilpatrick’s other leadership roles include being Chair of national audit in his field of medicine between 2004 and 2010 as well as providing expert advice to the UK Government and the National Institute for Health and Care Excellence (NICE) on aspects of diabetes care. He has also represented the UK on global task forces related to diabetes and laboratory medicine. Clinically, he has a quarter of a century experience in treating patients with diabetes, has led a clinic treating individuals with lipid disorders and has taken care of patients requiring intravenous nutrition.
Dr. Kilpatrick’s work has also led to him to become a seasoned presenter at diabetes and clinical biochemistry conferences, including 25 international meetings in the last decade. He has additionally gained recognition by receiving international lectures and awards from countries such as the UK, Canada and Australia.
- The obesity paradox in type 2 diabetes mellitus
- Using haemoglobin A1c to diagnose type 2 diabetes
- Glycemic control in the 12 months following a change
- Does severe hypoglycaemia influence microvascular complications in Type 1 diabetes?
- The effect of extensive flooding in Hull on the glycaemic control